ECR 2026 Preview: From Guidelines to Real-World Implementation
The official theme for ECR 2026 is "Rays of Knowledge." Inspired by the Owl of Athena—a symbol of vision capable of piercing through darkness—this year’s congress celebrates the radiologist's ability to reveal the hidden.
This resonates deeply with Coreline Soft. Just as the owl sees through the dark, our AI helps radiologists detect the subtlest nodules amidst the noise, sharpening the focus on early diagnosis. At ECR 2026, we move beyond theory to demonstrate how these "Rays of Knowledge" are being implemented in national lung cancer screening programs across Europe.
Event Overview: ECR 2026
Join Coreline Soft at Europe’s leading radiology congress.
• Date: March 4 ~ 8
• Venue: Austria Center Vienna (ACV), Vienna, Austria
• Booth: Hall X1, No.110
• Official Website:
https://www.myesr.org/congress/
Why ECR 2026 Matters
With strengthened lung cancer screening recommendations across Europe, the focus has shifted from "policy" to "execution." Building a national program requires standardized quality across hundreds of hospitals and diverse imaging equipment. ECR 2026 will go beyond technical showcases to address real-world strategies:
- Standardizing Workflows for national-scale programs.
- AI-driven QA to manage high screening volumes.
- Protocol Consistency across multi-vendor environments.
5 Key Trends to Watch
1. Real-World Implementation: Leading nations like the Netherlands, Italy, and France are accelerating adoption. Expect deep dives into Centralized Reading models, where AI ensures consistency across decentralized networks.
2. Practical Human-AI Teaming: The narrative has shifted from "replacement" to "efficiency." The spotlight is on Negative Triage—using AI to filter out normal cases so radiologists can focus on high-risk scans.
3. The 'Big-3' Screening Approach: One scan, three insights. Simultaneous analysis of Lung Cancer, COPD, and Coronary Artery Calcium (CAC) from a single Low-Dose CT (LDCT) is becoming the standard for cost-effective preventive care.
4. Safer Screening (UL-DCT): Sustainability requires safety. Technologies enabling diagnostic precision even at Ultra-Low Dose (UL-DCT) levels will be a major topic.
5. Seamless Integration: The best AI is invisible. Solutions that integrate flawlessly with PACS and Cloud systems—requiring zero extra clicks—will dominate the floor.
Coreline Soft at ECR 2026
Coreline Soft isn’t just attending ECR; we are setting the standard. Our technology powers some of Europe’s most significant screening trials:
•
EU (4-IN-THE-LUNG-RUN): A massive multinational trial spanning 5 countries and 26,000 participants.
• Germany (HANSE): Validated AI performance in Ultra-Low Dose settings, laying the groundwork for Germany’s national screening roadmap.
• Italy (RISP): Connecting 18 hospitals via a centralized reading platform.
• France (IMPULSION): A strategic implementation study across major French hospital networks.
With AVIEW LCS Plus, we have proven that our AI works in the real world. At ECR 2026, we will showcase the clinical data and operational models that are shaping the future of European lung screening.
ECR 2026 marks the transition to the
"Era of AI Standardization." Join us in Vienna to see how validated, field-tested AI solutions are redefining the standard of care.